Saputo Has Yet to Amass Durable Defenses Against Competitive and Macro Volatility
Saputo has maintained a sound balance sheet (with average net debt/adjusted EBITDA of 2.7 over the past five years), which helped it weather the covid pandemic while possessing sufficient liquidity.
West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...